查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1529742

临床前影像市场规模、份额、趋势分析报告：按产品、应用、最终用途、地区和细分市场进行预测，2024-2030 年

Preclinical Imaging Market Size, Share & Trends Analysis Report By Product (CT Imaging, Reagents, Services), By Application (R&D, Drug Discovery), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

临床前影像市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计2030年全球临床前影像市场规模将达59.6亿美元，2024年至2030年复合年增长率为4.55%。

对研发的大量投资正在推动世界各地的研究计划。因此，对临床前成像的需求正在稳步增长。製药、生物技术、生命科学、医疗设备和化妆品是成像模式广泛用于研发的应用领域。此外，兽医院和教育机构也在这个市场创造新的需求。

核子医学技术（主要是正子断层扫描（PET）和单光子发射电脑断层扫描（SPECT））、光学影像、微电脑（CT）、微磁振造影（MRI）、光声断层扫描（PAT）、超音波，是最重要的技术。每种方式都有其自身的优点和缺点。旨在提供有关正在研究的病理学过程的补充资讯的多重模式设备正在迅速流行，旨在克服每种成像模态的固有限制。微型 CT 和微型 MRI 等高解析度模式与提供微型 PET 和微型 SPECT 等功能资讯的高灵敏度技术相结合，不仅可用于感染疾病、肿瘤学、循环系统和神经病学。研究视野，有助于了解疾病的根本机制，同时也提供了评估新化学品和候选药物的高效且独特的工具，预计将有助于全球市场的成长。

全球市场的主要竞争对手正在采取各种措施丰富产品系列，包括推出新产品和提高製造能力。例如，在2023年2月举行的第75届印度放射影像协会上，富士软片印度公司宣布了设备和服务的开发。该公司于 2023 年 2 月 2 日至 5 日在阿姆利则举行的活动中展示了其尖端的诊断工具。最近推出的核磁共振造影系统APERTO Lucent 非 DICOM 印表机 APEOS 和超音波诊断设备Arietta 650 DeepInsight 和 Arietta 850 DeepInsight 都是新产品组合的组成部分。此外，还发布了智慧型手机应用程式「FUJIFILM Connect」。

此外，用于癌症研究和监测应用的高通量超音波成像系统的进步将推动市场发展。 2022 年 4 月，PerkinElmer 宣布扩展即时影像分析，以加速癌症、肾臟和肝臟疾病以及心臟病等领域的非侵入性临床研究和药物发现，推出了 Vega，一款具有完全功能的手持式超音波成像系统。鼓励使用非侵入性影像方法，因为它们减少了侵入性手术的需要，同时最大限度地减少了动物的不适。出于这种伦理考虑，临床前成像技术被采用。

临床前成像市场报告亮点

  • 以产品来看，光学成像领域由于在小动物成像和药物发现计划中的广泛使用，到2023年将占据最大的市场占有率，达到13.6%。
  • 由于技术进步和医疗保健基础设施的改善，研发领域在 2023 年获得了最大的市场占有率。
  • 以最终用途划分，製药和生物技术公司在 2023 年占据最大份额，达到 40.0%。製药和生物技术公司持续的研究活动和产品创新正在导致市场参与者的产品销售增加并推动市场成长。
  • 按地区划分，北美地区销售份额最大，2023年为29.75%。这是由于发达的研究基础设施、大量的临床前计划以及技术先进设备的高采用率。
  • 该行业的主要企业正在专注于引入先进的技术和能力，例如由人工智慧支援的系统。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章临床前影像市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 临床前影像市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章临床前影像市场：按产品分類的估计和趋势分析

  • 细分仪表板
  • 全球临床前影像市场波动分析：按产品
  • 2018-2030年全球临床前影像市场规模及趋势分析（依产品）
  • CT
  • MRI
  • PET/SPECT
  • 多模态
  • 光学
  • 超音波
  • 光声
  • 试剂
  • 服务

第五章临床前影像市场：按应用估计和趋势分析

  • 细分仪表板
  • 全球临床前影像市场波动分析：按应用分类
  • 2018-2030年全球临床前影像市场规模及趋势分析（按应用）
  • 研究与开发
  • 药物发现

第六章临床前影像市场：最终用途的估计和趋势分析

  • 细分仪表板
  • 全球临床前影像市场波动分析：依最终用途分类
  • 2018-2030 年全球临床前影像市场规模与趋势分析（依最终用途）
  • 製药和生物技术公司
  • 研究所
  • 其他的

第七章临床前影像市场：产品、应用和最终用途的区域估计和趋势分析

  • 2023 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概况
  • 2018-2030年市场规模、预测趋势分析：
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第八章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 2023年主要企业市场占有率分析
  • 公司定位分析
  • 公司分类（新兴企业、创新者、领导者）
  • 公司简介
    • Bruker Corporation
    • Siemens AG
    • General Electric（GE）
    • TriFoil Imaging
    • PerkinElmer, Inc.
    • VisualSonics Inc.（Fujifilm）
    • Mediso Ltd.
    • Agilent Technologies
    • MILabs BV
    • MR Solutions
    • Molecubes
Product Code: 978-1-68038-881-7

Preclinical Imaging Market Growth & Trends:

The global preclinical imaging market size is expected to reach USD 5.96 billion by 2030, registering a CAGR of 4.55% from 2024 to 2030, according to a new report by Grand View Research, Inc. Heavy investments in research and development are encouraging research projects worldwide. As a result, the demand for preclinical imaging is steadily increasing. Pharmaceuticals, biotechnology, life sciences, medical devices, and cosmetics are wide application areas, where imaging modalities are widely used in research and development. Furthermore, veterinary hospitals and educational institutions also create an additional demand for this market.

Nuclear medicine techniques (primarily, positron emission tomography (PET) and single photon emission computed tomography (SPECT)), optical imaging, micro-computed tomography (CT), micro magnetic resonance imaging (MRI), Photoacoustic tomography (PAT), and ultrasound are the most suitable modalities for small-animal in vivo imaging applications. Each modality has its own set of benefits and drawbacks. The multimodality devices designed to give complementary information on the pathophysiological process under research have rapidly gained popularity, seeking to overcome the inherent limits of each imaging modality. The combination of high-resolution modalities such as micro-CT and micro-MRI with highly sensitive techniques that provide functional information like micro-PET or micro-SPECT is expected to broaden the horizons of research in key areas like infection, oncology, cardiology, and neurology, contributing not only to the understanding of disease underlying mechanisms but also providing efficient and unique tools for evaluating new chemical entities and candidate drugs, thus boosting the global market growth.

The global market's prominent competitors are undertaking different initiatives for enhancing their product portfolio with novel product launches and enhancing their manufacturing capacity. For instance, In February 2023, at the 75th National Conference of the Indian Radiological and Imaging Association, FUJIFILM India announced the development of its equipment and service offerings. The company demonstrated cutting-edge diagnostic tools at the event in Amritsar from February 2-5, 2023. The recently released MRI machine APERTO Lucent Non DICOM printer APEOS and the ultrasound devices Arietta 650 DeepInsight and Arietta 850 DeepInsight are all components of the new portfolio. A smartphone application for assistance and guidance called "FUJIFILM Connect" was additionally released by the company.

Moreover, the advancements in the high-throughput ultrasound imaging system used in the application of cancer research and studies boost the market. In April 2022, the Vega imaging system, a handheld ultrasound system with fully automated technology and high-throughput capacity, which can speed up non-invasive clinical research and drug discovery in the fields of cancer, kidney and liver disease, and heart disease, was launched by PerkinElmer as an aspect of the company's announcement of a broadening of its live image analysis. The use of non-invasive imaging methods is encouraged since they reduce the need for invasive operations while minimizing animals' discomfort to a minimum. Preclinical imaging techniques have been adopted as a result of this ethical consideration.

Preclinical Imaging Market Report Highlights:

  • Based on product, The optical imaging segment held the largest market share of 13.6% in 2023 owing to its wide usage in small animal imaging and new drug discovery projects
  • The research & development segment captured the largest market share in 2023 owing to the technological advancements and improved healthcare infrastructure
  • In terms of end-use, the pharma and biotech companies segment captured the largest market share of 40.0% in 2023. The constant research activities and innovation of products in pharma & biotech companies have led market players to increase their product sales, driving market growth
  • Based on region, North America held the largest revenue share 29.75% in 2023 owing to the well-developed research infrastructure, a large number of preclinical projects, and higher adoption rates of technically advanced devices in the region can be attributed to this share
  • Major players in the industry are focusing on the launch of advanced technology and features such as artificial intelligence-enabled systems

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Preclinical Imaging Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Technological advancements
      • 3.2.1.2. Growing number of investments and funding in research and development
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Strict regulatory framework
  • 3.3. Preclinical Imaging Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Preclinical Imaging Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Preclinical Imaging Product Market Movement Analysis
  • 4.3. Global Preclinical Imaging Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. CT
    • 4.4.1. CT market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. MRI
    • 4.5.1. MRI market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. PET/SPECT
    • 4.6.1. PET/SPECT market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Multi Modal
    • 4.7.1. Multi modal market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.8. Optical
    • 4.8.1. Optical market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.9. Ultrasound
    • 4.9.1. Ultrasound market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.10. Photoacoustic
    • 4.10.1. Photoacoustic market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.11. Reagents
    • 4.11.1. Reagents market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.12. Services
    • 4.12.1. Services market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Preclinical Imaging Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Preclinical Imaging Application Market Movement Analysis
  • 5.3. Global Preclinical Imaging Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Research and Development
    • 5.4.1. Research and development market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Drug Discovery
    • 5.5.1. Drug discovery market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Preclinical Imaging Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Preclinical Imaging End Use Market Movement Analysis
  • 6.3. Global Preclinical Imaging Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Pharma and Biotech Companies
    • 6.4.1. Pharma and biotech companies market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Research Institutes
    • 6.5.1. Research institutes market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Preclinical Imaging Market: Regional Estimates & Trend Analysis By Product, Application, End Use

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Competitive scenario
      • 7.5.1.3. Regulatory framework
      • 7.5.1.4. Reimbursement structure
      • 7.5.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Competitive scenario
      • 7.5.2.3. Regulatory framework
      • 7.5.2.4. Reimbursement structure
      • 7.5.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Competitive scenario
      • 7.5.3.3. Regulatory framework
      • 7.5.3.4. Reimbursement structure
      • 7.5.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Competitive scenario
      • 7.6.1.3. Regulatory framework
      • 7.6.1.4. Reimbursement structure
      • 7.6.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. Regulatory framework
      • 7.6.2.4. Reimbursement structure
      • 7.6.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive scenario
      • 7.6.3.3. Regulatory framework
      • 7.6.3.4. Reimbursement structure
      • 7.6.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Competitive scenario
      • 7.6.4.3. Regulatory framework
      • 7.6.4.4. Reimbursement structure
      • 7.6.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Competitive scenario
      • 7.6.5.3. Regulatory framework
      • 7.6.5.4. Reimbursement structure
      • 7.6.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. Norway
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Competitive scenario
      • 7.6.6.3. Regulatory framework
      • 7.6.6.4. Reimbursement structure
      • 7.6.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Competitive scenario
      • 7.6.7.3. Regulatory framework
      • 7.6.7.4. Reimbursement structure
      • 7.6.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.8. Denmark
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Competitive scenario
      • 7.6.8.3. Regulatory framework
      • 7.6.8.4. Reimbursement structure
      • 7.6.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Competitive scenario
      • 7.7.1.3. Regulatory framework
      • 7.7.1.4. Reimbursement structure
      • 7.7.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Regulatory framework
      • 7.7.2.4. Reimbursement structure
      • 7.7.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive scenario
      • 7.7.3.3. Regulatory framework
      • 7.7.3.4. Reimbursement structure
      • 7.7.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Competitive scenario
      • 7.7.4.3. Regulatory framework
      • 7.7.4.4. Reimbursement structure
      • 7.7.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Competitive scenario
      • 7.7.5.3. Regulatory framework
      • 7.7.5.4. Reimbursement structure
      • 7.7.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Competitive scenario
      • 7.7.6.3. Regulatory framework
      • 7.7.6.4. Reimbursement structure
      • 7.7.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Competitive scenario
      • 7.8.1.3. Regulatory framework
      • 7.8.1.4. Reimbursement structure
      • 7.8.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.2. Argentina
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Competitive scenario
      • 7.8.2.3. Regulatory framework
      • 7.8.2.4. Reimbursement structure
      • 7.8.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Competitive scenario
      • 7.9.1.3. Regulatory framework
      • 7.9.1.4. Reimbursement structure
      • 7.9.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Competitive scenario
      • 7.9.2.3. Regulatory framework
      • 7.9.2.4. Reimbursement structure
      • 7.9.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Competitive scenario
      • 7.9.3.3. Regulatory framework
      • 7.9.3.4. Reimbursement structure
      • 7.9.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Competitive scenario
      • 7.9.4.3. Regulatory framework
      • 7.9.4.4. Reimbursement structure
      • 7.9.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Key company market share analysis, 2023
  • 8.4. Company Position Analysis
  • 8.5. Company Categorization (Emerging Players, Innovators and Leaders)
  • 8.6. Company Profiles
    • 8.6.1. Bruker Corporation
      • 8.6.1.1. Company overview
      • 8.6.1.2. Financial performance
      • 8.6.1.3. Product benchmarking
      • 8.6.1.4. Strategic initiatives
    • 8.6.2. Siemens A.G.
      • 8.6.2.1. Company overview
      • 8.6.2.2. Financial performance
      • 8.6.2.3. Product benchmarking
      • 8.6.2.4. Strategic initiatives
    • 8.6.3. General Electric (GE)
      • 8.6.3.1. Company overview
      • 8.6.3.2. Financial performance
      • 8.6.3.3. Product benchmarking
      • 8.6.3.4. Strategic initiatives
    • 8.6.4. TriFoil Imaging
      • 8.6.4.1. Company overview
      • 8.6.4.2. Financial performance
      • 8.6.4.3. Product benchmarking
      • 8.6.4.4. Strategic initiatives
    • 8.6.5. PerkinElmer, Inc.
      • 8.6.5.1. Company overview
      • 8.6.5.2. Financial performance
      • 8.6.5.3. Product benchmarking
      • 8.6.5.4. Strategic initiatives
    • 8.6.6. VisualSonics Inc. (Fujifilm)
      • 8.6.6.1. Company overview
      • 8.6.6.2. Financial performance
      • 8.6.6.3. Product benchmarking
      • 8.6.6.4. Strategic initiatives
    • 8.6.7. Mediso Ltd.
      • 8.6.7.1. Company overview
      • 8.6.7.2. Financial performance
      • 8.6.7.3. Product benchmarking
      • 8.6.7.4. Strategic initiatives
    • 8.6.8. Agilent Technologies
      • 8.6.8.1. Company overview
      • 8.6.8.2. Financial performance
      • 8.6.8.3. Product benchmarking
      • 8.6.8.4. Strategic initiatives
    • 8.6.9. MILabs B.V.
      • 8.6.9.1. Company overview
      • 8.6.9.2. Financial performance
      • 8.6.9.3. Product benchmarking
      • 8.6.9.4. Strategic initiatives
    • 8.6.10. MR Solutions
      • 8.6.10.1. Company overview
      • 8.6.10.2. Financial performance
      • 8.6.10.3. Product benchmarking
      • 8.6.10.4. Strategic initiatives
    • 8.6.11. Molecubes
      • 8.6.11.1. Company overview
      • 8.6.11.2. Financial performance
      • 8.6.11.3. Product benchmarking
      • 8.6.11.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America preclinical imaging market, By country, 2018 - 2030 (USD Million)
  • Table 3 North America preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 4 North America preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 5 North America preclinical imaging market, By end use, 2018 - 2030 (USD Million)
  • Table 6 U.S. preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 7 U.S. preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 8 U.S. preclinical imaging market, By end use, 2018 - 2030 (USD Million)
  • Table 9 Canada preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 10 Canada preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 11 Canada preclinical imaging market, By end use, 2018 - 2030 (USD Million)
  • Table 12 Mexico preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 13 Mexico preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 14 Mexico preclinical imaging market, By end use, 2018 - 2030 (USD Million)
  • Table 15 Europe preclinical imaging market, By country, 2018 - 2030 (USD Million)
  • Table 16 Europe preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 17 Europe preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 18 Europe preclinical imaging market, By end use, 2018 - 2030 (USD Million)
  • Table 19 UK preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 20 UK preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 21 UK preclinical imaging market, By end use, 2018 - 2030 (USD Million)
  • Table 22 Germany preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 23 Germany preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 24 Germany preclinical imaging market, By end use, 2018 - 2030 (USD Million)
  • Table 25 France preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 26 France preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 27 France preclinical imaging market, By end use, 2018 - 2030 (USD Million)
  • Table 28 Italy preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 29 Italy preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 30 Italy preclinical imaging market, By end use, 2018 - 2030 (USD Million)
  • Table 31 Denmark preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 32 Denmark preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 33 Denmark preclinical imaging market, By end use, 2018 - 2030 (USD Million)
  • Table 34 Sweden preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 35 Sweden preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 36 Sweden preclinical imaging market, By end use, 2018 - 2030 (USD Million)
  • Table 37 Norway preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 38 Norway preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 39 Norway preclinical imaging market, By end use, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific preclinical imaging market, By country, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific preclinical imaging market, By end use, 2018 - 2030 (USD Million)
  • Table 44 Japan preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 45 Japan preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 46 Japan preclinical imaging market, By end use, 2018 - 2030 (USD Million)
  • Table 47 China preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 48 China preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 49 China preclinical imaging market, By end use, 2018 - 2030 (USD Million)
  • Table 50 India preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 51 India preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 52 India preclinical imaging market, By end use, 2018 - 2030 (USD Million)
  • Table 53 Australia preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 54 Australia preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 55 Australia preclinical imaging market, By end use, 2018 - 2030 (USD Million)
  • Table 56 South Korea preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 57 South Korea preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 58 South Korea preclinical imaging market, By end use, 2018 - 2030 (USD Million)
  • Table 59 Thailand preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 60 Thailand preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 61 Thailand preclinical imaging market, By end use, 2018 - 2030 (USD Million)
  • Table 62 Latin America preclinical imaging market, By Country, 2018 - 2030 (USD Million)
  • Table 63 Latin America preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 64 Latin America preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 65 Latin America preclinical imaging market, By end use, 2018 - 2030 (USD Million)
  • Table 66 Brazil preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 67 Brazil preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 68 Brazil preclinical imaging market, By end use, 2018 - 2030 (USD Million)
  • Table 69 Argentina preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 70 Argentina preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 71 Argentina preclinical imaging market, By end use, 2018 - 2030 (USD Million)
  • Table 72 Middle East & Africa preclinical imaging market, By country, 2018 - 2030 (USD Million)
  • Table 73 Middle East & Africa preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 74 Middle East & Africa preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 75 Middle East & Africa preclinical imaging market, By end use, 2018 - 2030 (USD Million)
  • Table 76 South Africa preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 77 South Africa preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 78 South Africa preclinical imaging market, By end use, 2018 - 2030 (USD Million)
  • Table 79 Saudi Arabia preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 80 Saudi Arabia preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 81 Saudi Arabia preclinical imaging market, By end use, 2018 - 2030 (USD Million)
  • Table 82 UAE preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 83 UAE preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 84 UAE preclinical imaging market, By end use, 2018 - 2030 (USD Million)
  • Table 85 Kuwait preclinical imaging market, By product, 2018 - 2030 (USD Million)
  • Table 86 Kuwait preclinical imaging market, By application, 2018 - 2030 (USD Million)
  • Table 87 Kuwait preclinical imaging market, By end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Dermatology imaging devices market: Market outlook
  • Fig. 14 Dermatology imaging devices market competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Preclinical imaging market driver impact
  • Fig. 20 Preclinical imaging restraint impact
  • Fig. 21 Preclinical imaging market: product movement analysis
  • Fig. 22 Preclinical imaging market: product outlook and key takeaways
  • Fig. 23 CT market estimates and forecast, 2018 - 2030
  • Fig. 24 MRI market estimates and forecast, 2018 - 2030
  • Fig. 25 PET/SPECT market estimates and forecast, 2018 - 2030
  • Fig. 26 Multi Modal market estimates and forecast, 2018 - 2030
  • Fig. 27 Optical market estimates and forecast, 2018 - 2030
  • Fig. 28 Ultrasound market estimates and forecast, 2018 - 2030
  • Fig. 29 Photoacoustic market estimates and forecast, 2018 - 2030
  • Fig. 30 Reagents market estimates and forecast, 2018 - 2030
  • Fig. 31 Services market estimates and forecast, 2018 - 2030
  • Fig. 32 Preclinical imaging market: application movement analysis
  • Fig. 33 Preclinical imaging market: application outlook and key takeaways
  • Fig. 34 Research and development market estimates and forecast, 2018 - 2030
  • Fig. 35 Drug discovery market estimates and forecast, 2018 - 2030
  • Fig. 36 Preclinical imaging market: end use movement analysis
  • Fig. 37 Preclinical imaging market: end use outlook and key takeaways
  • Fig. 38 Pharma and biotech companies market estimates and forecast, 2018 - 2030
  • Fig. 39 Research institutes market estimates and forecast, 2018 - 2030
  • Fig. 40 Global Dermatology imaging devices market: regional movement analysis
  • Fig. 41 Global Dermatology imaging devices market: regional outlook and key takeaways
  • Fig. 42 North America
  • Fig. 43 North America market estimates and forecast, 2018 - 2030
  • Fig. 44 U.S.
  • Fig. 45 U.S. market estimates and forecast, 2018 - 2030
  • Fig. 46 Canada
  • Fig. 47 Canada market estimates and forecast, 2018 - 2030
  • Fig. 48 Mexico
  • Fig. 49 Mexico market estimates and forecast, 2018 - 2030
  • Fig. 50 Europe
  • Fig. 51 Europe. market estimates and forecast, 2018 - 2030
  • Fig. 52 UK
  • Fig. 53 UK market estimates and forecast, 2018 - 2030
  • Fig. 54 Germany
  • Fig. 55 Germany market estimates and forecast, 2018 - 2030
  • Fig. 56 France
  • Fig. 57 France market estimates and forecast, 2018 - 2030
  • Fig. 58 Italy
  • Fig. 59 Italy market estimates and forecast, 2018 - 2030
  • Fig. 60 Spain
  • Fig. 61 Spain market estimates and forecast, 2018 - 2030
  • Fig. 62 Denmark
  • Fig. 63 Denmark market estimates and forecast, 2018 - 2030
  • Fig. 64 Sweden
  • Fig. 65 Sweden market estimates and forecast, 2018 - 2030
  • Fig. 66 Norway
  • Fig. 67 Norway market estimates and forecast, 2018 - 2030
  • Fig. 68 Asia Pacific
  • Fig. 69 Asia Pacific market estimates and forecast, 2018 - 2030
  • Fig. 70 Japan
  • Fig. 71 Japan market estimates and forecast, 2018 - 2030
  • Fig. 72 China
  • Fig. 73 China market estimates and forecast, 2018 - 2030
  • Fig. 74 India
  • Fig. 75 India market estimates and forecast, 2018 - 2030
  • Fig. 76 South Korea
  • Fig. 77 South Korea market estimates and forecast, 2018 - 2030
  • Fig. 78 Thailand
  • Fig. 79 Thailand market estimates and forecast, 2018 - 2030
  • Fig. 80 Australia
  • Fig. 81 Australia market estimates and forecast, 2018 - 2030
  • Fig. 82 Latin America
  • Fig. 83 Latin America market estimates and forecast, 2018 - 2030
  • Fig. 84 Brazil
  • Fig. 85 Brazil market estimates and forecast, 2018 - 2030
  • Fig. 86 Argentina
  • Fig. 87 Argentina market estimates and forecast, 2018 - 2030
  • Fig. 88 Middle East and Africa
  • Fig. 89 Middle East and Africa. market estimates and forecast, 2018 - 2030
  • Fig. 90 Saudi Arabia
  • Fig. 91 Saudi Arabia market estimates and forecast, 2018 - 2030
  • Fig. 92 South Africa
  • Fig. 93 South Africa market estimates and forecast, 2018 - 2030
  • Fig. 94 UAE
  • Fig. 95 UAE market estimates and forecast, 2018 - 2030
  • Fig. 96 Kuwait
  • Fig. 97 Kuwait market estimates and forecast, 2018 - 2030
  • Fig. 98 Participant categorization- Preclinical imaging market
  • Fig. 99 Market share of key market players- Preclinical imaging market